Bayvrio
PrivateLast Round
Strategic
Mar 11, 2025
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bayvrio is a health technology company that provides a modular, tech-driven pharmacy benefit management marketplace for healthcare payers.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Pharma Supply Chain
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bayvrio Comparables
Compare Bayvrio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EVERSANA | 78% | |
| Truveris | 77% | |
| RxSense | 77% | |
Bayvrio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 11, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 41% QoQ from 17 to 24 employees.
- Jul 24, 2026
Monthly visitors grew 121% MoM to 1.7K.
Bayvrio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bayvrio's valuation, stock price, and market status.